Abbvie (ABBV) Operating Margin (2012 - 2026)
Abbvie (ABBV) operating margin from Mar 31, 2012 to Mar 31, 2026. The current Abbvie (ABBV) operating margin is 26.60%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Abbvie (ABBV)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 24.65% | +51.97% |
| 2024 | 16.22% | -30.94% |
| 2023 | 23.49% | -24.74% |
| 2022 | 31.21% | -2.16% |
| 2021 | 31.89% | +28.57% |
| 2020 | 24.81% | -36.44% |
| 2019 | 39.03% | +100.26% |
| 2018 | 19.49% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 33.83% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | 36.43% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | 32.97% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | 17.09% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | 30.14% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 31.65% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | 20.75% | N/A |
Comparison Abbvie (ABBV) operating margin with competitors
Abbvie (ABBV) operating margin is 26.60%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | +131.50% |
| GILD | Gilead Sciences Inc | 37.16% | +39.72% |
| NVS | Novartis AG | 31.31% | +17.72% |
| AMGN | AMGEN Inc | 30.94% | +16.33% |
| GSK | GSK Plc | 30.06% | +13.02% |
| AZN | Astrazeneca plc | 27.77% | +4.41% |
| JNJ | Johnson & Johnson | 26.58% | -0.06% |
| SNY | Sanofi | 20.18% | -24.13% |
| OGN | Organon & Company | 18.22% | -31.49% |
| GRFS | Grifols SA | 14.65% | -44.92% |